Page 1931 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

1358 Index

Tissue hypoxia, 842 agitated or seizing patient, 1197, 1197t Transfusion, sickle cell disease and,
Tissue oximetry, 244–245 alterations in temperature, 913–914, 913t, 914t
Tissue oxygenation, 242–245, 243f, 1197–1198, 1197t Transfusion-related immunomodulation and
244t, 245f coma cocktail, 1196–1197 age of transfused red blood cells,
Tobramycin, 547 poison control centers, 1203 843–844
Tocolytic therapy in pregnancy, 1266 specific intoxications, 1206–1223 Transjugular intrahepatic portosystemic shunt
Togaviridae, 673 acetaminophen, 1206–1210, (TIPS) procedure,
Tonicity, 944 1207f, 1209t 24f, 223–225, 928, 1009
Torsade de pointes, 281 amphetamines, 1210 Translational research in rehabilitation after
Torso trauma, 1152–1168, 1153f barbiturates, 1210 critical illness, 110
abdominal injuries in, 1160–1161 benzodiazepines, 1210–1211 Transmission-based precautions, 28–30, 29t
https://kat.cr/user/tahir99/
classification of, 1153 calcium-channel blockers, 1211–1212 Transplant patient, 1087–1108
emergency thoracotomy, 1157–1160 carbon monoxide, 1212 heart transplantation, 1102–1108
aortic rupture, 1159–1160, 1159f cocaine, 1212–1214, 1213f indications and outcomes, 1102
blunt cardiac injury, 1159 cyanide, 1214–1215 infectious complications,
cardiac tamponade, 1157–1158 cyclic antidepressants, 1215–1216 1104–1107, 1105ft, 1107t
diaphragmatic rupture, 1160 digoxin, 1216–1217, 1216t postoperative complications,
esophageal disruption, 1160 envenomations, 1222–1223 1103–1104, 1104t
indications, 1157 lithium, 1217–1218 postoperative management, 1102–1103
lung contusion, 1158 methemoglobinemia, 1218–1219 procedures, 1102
rib fractures, 1160 opioids, 1219 immunosuppression, 1088–1090, 1088f
simple hemopneumothorax, 1160 organophosphate and carbamate antilymphocyte antibodies, 1089–1090
massively bleeding patient, 1156–1157 insecticides, 1219–1220, 1219t calcineurin inhibitors and related
flail chest, 1157 salicylates, 1220–1221, 1220t, 1221t compounds, 1089
pneumothorax and tracheobronchial selective serotonin reuptake inhibitors, new agents, 1090
injury, 1156–1157 1221–1222, 1221t proliferation inhibitors, 1089
traumatic air embolism, 1157 ß-blockers, 1211 systemic corticosteroids, 1090
specific abdominal injuries, 1162–1168 γ-hydroxybutyrate, 1217 liver transplantation, 1097–1102
duodenal, 1162–1163, 1162f Toxicology screening, 1202–1203, changes in donor demographic and
extrahepatic biliary tract, 1165–1166 1202t, 1203t management, 1098
genitourinary, 1166–1167 Toxic shock syndrome (TSS), 564, indications and outcomes, 1097–1098,
intestinal, 1163–1164 1297, 1297t 1097t, 1098ft
liver, 1164–1165 Toxidrome, 1198 postoperative complications,
pancreatic, 1163 Toxoplasma gondii, 675–676 1100–1102, 1100t, 1101t
retroperitoneal hemorrhage, 1166 Toxoplasmosis, 675–676 procedure, 1098–1099
spleen, 1165 Trachea, 404 lung transplantation, 1090–1096
stomach, 1162 Tracheal deviation, 505 indications and outcomes, 1090–1092,
traumatic abdominal compartment Tracheal intubation, 384 1090t, 1091ft, 1092ft
syndrome, 1167–1168 Tracheo-innominate fistula, 395, 400 postoperative complications, 1093–1096,
thoracic injuries requiring immediate Tracheostomy, 394–395, 396–404, 1309 1094t, 1095t, 1096f
intervention, 1153–1157 areas of continued controversy and future postoperative management, 1093, 1094t
cardiac tamponade, 1155–1156 study, 403 procedure, 1093
massive hemothorax, 1156 benefits and risks of, 397–398, 397t Transplant surgery emergencies,
open pneumothorax, complications of, 395 1074–1075, 1076t
1154–1155, 1155f emergency cricothyroidotomy and, 400 Transportation, of critically ill patient, 69–76
tension pneumothorax, 1154, 1154f indications for, 394, 396–397, 397t prior to transfer, 69–75, 70t, 71–7271t,
Toxicology in adults, 1192–1223 management of, 400–401 74ft, 75f
detoxification, 1203–1206 minitracheostomy, 395 special circumstances/clinical conditions,
activated charcoal, 1203–1204 percutaneous versus surgical, 394–395 75–76, 76t
extracorporeal removal of toxins, selection of tube, 401 Transpulmonary indicator dilution, 247
1205–1206 speech and swallowing, 403 Transtentorial uncal herniation, 1123
forced diuresis and urinary technique of, 399–400 Trauma. See also Torso trauma
manipulations, 1204–1205, 1204t timing of, 398 ECMO in, 481, 481t
gastric emptying, 1203 weaning from, and decannulation, 401, electric, 1175–1180, 1176t, 1177t
whole-bowel irrigation, 1204 402f, 403 cardiac, 1177
diagnosis of toxic ingestion, 1198–1203 Tracheostomy tube, selection of, 401 extremity and wound, 1178–1179
history and physical examination, TRAF-associated kinase (TAK), 552 gastrointestinal, 1178
1198–1199, 1198t, 1199t, 1200t Tranexamic acid, 1279 initial evaluation, 1176–1177
laboratory evaluation, 1199–1202, Tranexamic acid and aminocaproic acid, 857 late sequelae of injury, 1179–1180
1200t, 1201t Transcalvarial herniation, 1123 lightning injury, 1179
toxicology screening, 1202–1203, Transesophageal echocardiography, 1056 neurologic, 1178
1202t, 1203t Transforming growth factor (TGF), 566 pulmonary, 1178
indications for intensive care unit Transfused red blood cells, renal, 1177–1178
admission, 1206 transfusion-related extremities, 1172–1175
initial supportive measures, immunomodulation and complications in, 1173–1175, 1174f
1194–1198, 1194t, 1195t age of, 843–844 electrical, 1178

Index.indd 1358 23-01-2015 15:33:54